Ilan S Weisberg
Overview
Explore the profile of Ilan S Weisberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zaher A, Elsaygh J, Peterson S, Weisberg I, Parikh M, Frishman W
Cardiol Rev
. 2024 Apr;
PMID: 38666794
The intricate ecosystem of the mammalian gut, which hosts a diverse microbiome, plays a vital role in various physiological functions. Trillions of bacteria within the gut contribute to host metabolism,...
2.
Yee A, Huang S, Singh R, Rizzi D, Shama N, Khoury N, et al.
JGH Open
. 2024 Jan;
8(1):e13011.
PMID: 38268953
Disseminated histoplasmosis is a rare complication of infection due to . Typically, histoplasmosis is self-limiting and asymptomatic in infected individuals with immunocompetence. Disseminated disease, however, can arise in high-risk populations...
3.
Golfeyz S, Lewis S, Weisberg I
Expert Rev Gastroenterol Hepatol
. 2018 Jul;
12(8):767-778.
PMID: 29966105
Hereditary hemochromatosis (HH) is an autosomal recessive disorder that occurs in approximately 1 in 200-250 individuals. Mutations in the HFE gene lead to excess iron absorption. Excess iron in the...
4.
Weisberg I, Jacobson I
Clin Liver Dis
. 2017 Oct;
21(4):659-672.
PMID: 28987254
Treatment of hepatitis C virus has been vastly transformed by the arrival of all-oral, interferon-free, direct-acting antiviral regimens. Despite the high rate of success with these agents, a small portion...
5.
Mangla N, Mamun R, Weisberg I
Eur J Gastroenterol Hepatol
. 2017 Sep;
29(11):1215-1218.
PMID: 28857896
Background And Aim: Viral hepatitis is a global health issue and can lead to cirrhosis, liver failure, and hepatocellular carcinoma. Guidelines for viral hepatitis screening in the transgender population do...
6.
Weisberg I, Jacobson I
Expert Opin Pharmacother
. 2017 Jan;
18(5):535-543.
PMID: 28092171
Hepatitis C virus (HCV) infects nearly 170 million people worldwide and is a leading cause of progressive liver damage, cirrhosis, and hepatocellular carcinoma. Curative therapies have historically relied on interferon-based...
7.
Weisberg I, Jacobson I
Clin Liver Dis
. 2010 Nov;
15(1):1-20.
PMID: 21111990
The dual blood supply of the liver, originating from the portal vein and the hepatic artery, makes it relatively resistant to minor circulatory disturbances. However, hepatic manifestations of common cardiovascular...
8.
Weisberg I, Jacobson I
Clin Liver Dis
. 2009 Jul;
13(3):441-52.
PMID: 19628160
Standard therapy with pegylated interferon and ribavirin for chronic hepatitis C is effective in 40% to 50% of individuals with genotype 1 hepatitis C virus (HCV) infection and is associated...
9.
Weisberg I, Brown Jr R, Sigal S
Clin Liver Dis
. 2007 Nov;
11(4):893-916, ix.
PMID: 17981234
Hepatitis B virus (HBV) is the most common cause of chronic hepatitis and end-stage liver disease worldwide. Untreated, chronic hepatitis B acquired early in life results in cirrhosis, liver failure,...
10.
Weisberg I, Park E, Ballman K, Berger P, Nunn M, Suh D, et al.
Atherosclerosis
. 2003 Jun;
167(2):205-14.
PMID: 12818402
Hyperhomocysteinemia, a risk factor for cardiovascular disease, can be caused by genetic mutations in enzymes of homocysteine metabolism. Homocysteine remethylation to methionine is catalyzed by folate-dependent methionine synthase, or by...